Business services providers thrive by solving complex operational challenges for their clients, allowing them to focus on ...

The case involved a clinical trial of Akero's only product, a drug candidate aimed at treating a liver disease. It's the ...

Equifax faces growth headwinds, premium valuation, and flat price action despite AI and cloud investments, with limited ...

Equifax® (NYSE: EFX) today announced that the Equifax Board of Directors declared a quarterly dividend of $0.50 per share, payable on September 15, 2025, to shareholders of record as of the close of ...

Let's take a closer look.Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with ...

Credit reporting giant Equifax (NYSE:EFX) announced in Q2 CY2025, with sales up 7.4% year on year to $1.54 billion. On the other hand, next quarter’s revenue guidance of $1.52 billion was less ...

EFX delivered a strong 2Q25 beat, with both top- and bottom-line beating consensus expectations, which was impressive given the still-challenging macro backdrop.

Equifax Inc. Annual stock financials by MarketWatch. View the latest EFX financial statements, income statements and financial ratios.

EQUIFAX INC (EFX) is a large-cap growth stock in the Business Services industry. The rating using this strategy is 66% based on the firm’s underlying fundamentals and the stock’s valuation.